Details of the Drug
General Information of Drug (ID: DMHEV75)
Drug Name |
Preclamol
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
UNII-9V2O6CRQ6Z; CHEMBL7549; 9V2O6CRQ6Z; Preclamol [INN]; Preclamolum [Latin]; 85966-89-8; Preclamolum; 3-(1-Propyl-piperidin-3-yl)-phenol; (-)-(S)-m-(1-Propyl-3-piperidyl)phenol; AC1NSK6E; Lopac0_000996; SCHEMBL1240854; DTXSID7048453; ZINC402947; 3PPP,(+); 3-PPP-(-); PDSP2_000626; BDBM50010617; PDSP1_000630; CCG-205076; NCGC00162308-01; NCGC00162310-02; (S)-3-(1-propylpiperidin-3-yl)phenol; 3-[(3S)-1-propylpiperidin-3-yl]phenol; 3-((S)-1-Propyl-piperidin-3-yl)-phenol; (-)-3-(1-Propyl-piperidin-3-yl)-phenol; FT-0770905
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure | ||||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 219.32 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 3 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References